ProShares Ultra Bitcoin ETF vs Medpace Holdings Inc — how do they compare? ProShares Ultra Bitcoin ETF trades at $9.16, while Medpace Holdings Inc trades at $602.04 (market cap $16.90B). The key difference: Medpace Holdings Inc is trading nearer its 52-week high, ProShares Ultra Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| BITU | MEDP | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $64.41 | $620.59 |
52-Week Low | $8.12 | $393.42 |
Market Cap | — | $16.90B |
Enterprise Value | — | $16.52B |
Signals from Pluang's Aura AI — not financial advice
BITU's stock trades at $9.205, down 1.34% in the last 24 hours, with a bearish technical signal from moving averages and a neutral stance from oscillators. The company has declared several dividends in 2026, with the latest being $0.02 per share. Key support and resistance levels are tightly clustered around $9 to $10, indicating limited recent price movement.
The outlook for BITU is cautious due to bearish technical indicators and negative sentiment from financial media. Investment opportunities may exist for dividend-focused investors, but risks include potential underperformance highlighted by analysts and market volatility. The stock's proximity to support levels suggests vulnerability to further declines.
MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.
Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.
Trailing returns across standard periods
Latest headlines on both assets
BITU is a leveraged ETF that seeks to provide two times (2x) the daily performance of Bitcoin. It is designed for sophisticated investors looking for magnified exposure to Bitcoin’s daily price movements.
Read more on BITU →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →